For recipients with undiagnosed diabetes or a history of oral antidiabetic medication use, a fixed dose of intermediate‐ or long‐acting insulin may initially be considered to manage glucocorticoid‐induced hyperglycaemia. This evidence concerns the gene INS and Hyperglycemia.